Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Reply to Piquereau and Perros, and to Pullamsetti and de Jesus Perez.

Kurakula K, Boucherat O, Van der Feen DE, Bogaard HJ, Kulikowski E, Bartelds B, Provencher S, Berger RMF, Bonnet S, Goumans MJ.

Am J Respir Crit Care Med. 2019 Aug 16. doi: 10.1164/rccm.201905-1078LE. [Epub ahead of print] No abstract available.

PMID:
31419387
2.

Intervening with the Nitric Oxide Pathway to Alleviate Pulmonary Hypertension in Pulmonary Vein Stenosis.

Duin RWBV, Stam K, Uitterdijk A, Bartelds B, Danser AHJ, Reiss IKM, Duncker DJ, Merkus D.

J Clin Med. 2019 Aug 12;8(8). pii: E1204. doi: 10.3390/jcm8081204.

3.

A case report on endarteritis in a child with coarctation of aorta.

Gnanam D, Bartelds B, van Leeuwen WJ, Frohn-Mulder IM, Koopman LP.

Echocardiography. 2019 Jul;36(7):1427-1430. doi: 10.1111/echo.14418. Epub 2019 Jun 25.

PMID:
31237036
4.

Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.

Van der Feen DE, Kurakula K, Tremblay E, Boucherat O, Bossers GP, Szulcek R, Bourgeois A, Lampron MC, Habbout K, Martineau S, Paulin R, Kulikowski E, Jahagirdar R, Schalij I, Bogaard HJ, Bartelds B, Provencher S, Berger RMF, Bonnet S, Goumans MJ.

Am J Respir Crit Care Med. 2019 May 1. doi: 10.1164/rccm.201812-2275OC. [Epub ahead of print]

PMID:
31042405
5.

Right ventricular pressure overload alters cardiac lipid composition.

Koop AMC, Hagdorn QAJ, Bossers GPL, van Leusden T, Gerding A, van Weeghel M, Vaz FM, Koonen DPY, Silljé HHW, Berger RMF, Bartelds B.

Int J Cardiol. 2019 Jul 15;287:96-105. doi: 10.1016/j.ijcard.2019.04.004. Epub 2019 Apr 8.

PMID:
31003793
6.

EXPRESS: Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.

van der Graaf M, Rojer LA, Helbing W, Reiss I, Etnel JRG, Bartelds B.

Pulm Circ. 2019 Feb 26:2045894019837875. doi: 10.1177/2045894019837875. [Epub ahead of print] No abstract available.

PMID:
30803328
7.

Converging Paths of Pulmonary Arterial Hypertension and Cellular Senescence.

van der Feen DE, Berger RMF, Bartelds B.

Am J Respir Cell Mol Biol. 2019 Jul;61(1):11-20. doi: 10.1165/rcmb.2018-0329TR.

PMID:
30758225
8.

Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease.

van der Feen DE, Bartelds B, de Boer RA, Berger RMF.

Heart. 2018 Nov 22. pii: heartjnl-2018-314025. doi: 10.1136/heartjnl-2018-314025. [Epub ahead of print] Review.

PMID:
30467194
9.

Right ventricular function in infants with bronchopulmonary dysplasia and pulmonary hypertension: a pilot study.

Blanca AJ, Duijts L, van Mastrigt E, Pijnenburg MW, Ten Harkel DD, Helbing WA, Bartelds B, Reis I, Koopman LP.

Pulm Circ. 2019 Jan-Mar;9(1):2045894018816063. doi: 10.1177/2045894018816063. Epub 2018 Nov 13.

10.

Volume load-induced right ventricular dysfunction in animal models: insights in a translational gap in congenital heart disease.

Bossers GPL, Hagdorn QAJ, Ploegstra MJ, Borgdorff MAJ, Silljé HHW, Berger RMF, Bartelds B.

Eur J Heart Fail. 2018 Apr;20(4):808-812. doi: 10.1002/ejhf.931. Epub 2017 Sep 18. Review. No abstract available.

11.

Fontan Circulation over Time.

Wolff D, van Melle JP, Bartelds B, Ridderbos FS, Eshuis G, van Stratum EBHJ, Recinos SJ, Willemse BWM, Hillege H, Willems TP, Ebels T, Berger RMF.

Am J Cardiol. 2017 Aug 1;120(3):461-466. doi: 10.1016/j.amjcard.2017.05.005. Epub 2017 May 11.

PMID:
28624095
12.

Diagnostic value of Doppler echocardiography for identifying hemodynamic significant pulmonary valve regurgitation in tetralogy of Fallot: comparison with cardiac MRI.

Beurskens NEG, Gorter TM, Pieper PG, Hoendermis ES, Bartelds B, Ebels T, Berger RMF, Willems TP, van Melle JP.

Int J Cardiovasc Imaging. 2017 Nov;33(11):1723-1730. doi: 10.1007/s10554-017-1165-4. Epub 2017 May 31.

13.

Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease.

van der Feen DE, Bartelds B, de Boer RA, Berger RMF.

Eur Heart J. 2017 Jul 7;38(26):2034-2041. doi: 10.1093/eurheartj/ehx034. Review.

PMID:
28369399
14.

Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up.

Ploegstra MJ, Brokelman JGM, Roos-Hesselink JW, Douwes JM, van Osch-Gevers LM, Hoendermis ES, van den Bosch AE, Witsenburg M, Bartelds B, Hillege HL, Berger RMF.

Eur Heart J Cardiovasc Imaging. 2018 Feb 1;19(2):216-224. doi: 10.1093/ehjci/jex015.

PMID:
28329155
15.

Near-infrared spectroscopy as a predictor of clinical deterioration: a case report of two infants with duct-dependent congenital heart disease.

Mebius MJ, du Marchie Sarvaas GJ, Wolthuis DW, Bartelds B, Kneyber MCJ, Bos AF, Kooi EMW.

BMC Pediatr. 2017 Mar 16;17(1):79. doi: 10.1186/s12887-017-0839-3.

16.

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension.

van der Feen DE, Weij M, Smit-van Oosten A, Jorna LM, Hagdorn QA, Bartelds B, Berger RM.

J Vis Exp. 2017 Feb 11;(120). doi: 10.3791/55065.

17.

Diminished liver microperfusion in Fontan patients: A biexponential DWI study.

Dijkstra H, Wolff D, van Melle JP, Bartelds B, Willems TP, Oudkerk M, Hillege H, van den Berg AP, Ebels T, Berger RM, Sijens PE.

PLoS One. 2017 Mar 3;12(3):e0173149. doi: 10.1371/journal.pone.0173149. eCollection 2017.

18.

Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint.

Zijlstra WMH, Ploegstra MJ, Vissia-Kazemier T, Roofthooft MTR, Sarvaas GDM, Bartelds B, Rackowitz A, van den Heuvel F, Hillege HL, Plasqui G, Berger RMF.

Am J Respir Crit Care Med. 2017 Jul 15;196(2):220-227. doi: 10.1164/rccm.201608-1576OC.

PMID:
28178426
19.

Serially Measured Uric Acid Levels Predict Disease Severity and Outcome in Pediatric Pulmonary Arterial Hypertension.

Leberkühne LJ, Ploegstra MJ, Douwes JM, Bartelds B, Roofthooft MT, Hillege HL, Berger RM.

Am J Respir Crit Care Med. 2017 Feb 1;195(3):401-404. doi: 10.1164/rccm.201606-1152LE. No abstract available.

PMID:
28145758
20.

Egr-1 identifies neointimal remodeling and relates to progression in human pulmonary arterial hypertension.

van der Feen DE, Dickinson MG, Bartelds B, Borgdorff MA, Sietsma H, Lévy M, Berger RM.

J Heart Lung Transplant. 2016 Apr;35(4):481-90. doi: 10.1016/j.healun.2015.12.004. Epub 2015 Dec 17.

PMID:
26774383
21.

The Fontan circulation and the liver: A magnetic resonance diffusion-weighted imaging study.

Wolff D, van Melle JP, Dijkstra H, Bartelds B, Willems TP, Hillege H, van den Berg AP, Ebels T, Sijens PE, Berger RM.

Int J Cardiol. 2016 Jan 1;202:595-600. doi: 10.1016/j.ijcard.2015.09.088. Epub 2015 Sep 28.

PMID:
26447669
22.

Erythropoietin Attenuates Pulmonary Vascular Remodeling in Experimental Pulmonary Arterial Hypertension through Interplay between Endothelial Progenitor Cells and Heme Oxygenase.

van Loon RL, Bartelds B, Wagener FA, Affara N, Mohaupt S, Wijnberg H, Pennings SW, Takens J, Berger RM.

Front Pediatr. 2015 Aug 28;3:71. doi: 10.3389/fped.2015.00071. eCollection 2015.

23.

Pulmonary regurgitant volume is superior to fraction using background-corrected phase contrast MRI in determining the severity of regurgitation in repaired tetralogy of Fallot.

Gorter TM, van Melle JP, Freling HG, Ebels T, Bartelds B, Pieper PG, Berger RM, van Veldhuisen DJ, Willems TP.

Int J Cardiovasc Imaging. 2015 Aug;31(6):1169-77. doi: 10.1007/s10554-015-0670-6. Epub 2015 May 6.

24.

Right ventricular failure due to chronic pressure load: What have we learned in animal models since the NIH working group statement?

Borgdorff MA, Dickinson MG, Berger RM, Bartelds B.

Heart Fail Rev. 2015 Jul;20(4):475-91. doi: 10.1007/s10741-015-9479-6. Review.

25.

Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.

Ploegstra MJ, Roofthooft MT, Douwes JM, Bartelds B, Elzenga NJ, van de Weerd D, Hillege HL, Berger RM.

Circ Cardiovasc Imaging. 2014 Dec 31;8(1). pii: e000878. doi: 10.1161/CIRCIMAGING.113.000878. Print 2015 Jan.

PMID:
25552488
26.

Clinical symptoms of right ventricular failure in experimental chronic pressure load are associated with progressive diastolic dysfunction.

Borgdorff MA, Koop AM, Bloks VW, Dickinson MG, Steendijk P, Sillje HH, van Wiechen MP, Berger RM, Bartelds B.

J Mol Cell Cardiol. 2015 Feb;79:244-53. doi: 10.1016/j.yjmcc.2014.11.024. Epub 2014 Dec 5.

PMID:
25486580
27.

A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension.

Dickinson MG, Kowalski PS, Bartelds B, Borgdorff MA, van der Feen D, Sietsma H, Molema G, Kamps JA, Berger RM.

Cardiovasc Res. 2014 Sep 1;103(4):573-84. doi: 10.1093/cvr/cvu169. Epub 2014 Jul 14.

PMID:
25028387
28.

Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload.

Borgdorff MA, Bartelds B, Dickinson MG, van Wiechen MP, Steendijk P, de Vroomen M, Berger RM.

Am J Physiol Heart Circ Physiol. 2014 Aug 1;307(3):H361-9. doi: 10.1152/ajpheart.00843.2013. Epub 2014 May 30.

29.

Ventricular remodelling after pulmonary valve replacement: comparison between pressure-loaded and volume-loaded right ventricles.

Gorter TM, van Melle JP, Hillege HL, Pieper PG, Ebels T, Hoendermis ES, Bartelds B, Willems TP, Berger RM.

Interact Cardiovasc Thorac Surg. 2014 Jul;19(1):95-101. doi: 10.1093/icvts/ivu097. Epub 2014 Apr 9.

PMID:
24722515
30.

Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre.

Douwes JM, Roofthooft MT, Van Loon RL, Ploegstra MJ, Bartelds B, Hillege HL, Berger RM.

Heart. 2014 Feb;100(3):224-30. doi: 10.1136/heartjnl-2013-304895.

PMID:
24390161
31.

Effect of right ventricular outflow tract obstruction on right ventricular volumes and exercise capacity in patients with repaired tetralogy of fallot.

Freling HG, Willems TP, van Melle JP, van Slooten YJ, Bartelds B, Berger RM, van Veldhuisen DJ, Pieper PG.

Am J Cardiol. 2014 Feb 15;113(4):719-23. doi: 10.1016/j.amjcard.2013.10.049. Epub 2013 Nov 25.

PMID:
24355311
32.

A cornerstone of heart failure treatment is not effective in experimental right ventricular failure.

Borgdorff MA, Bartelds B, Dickinson MG, Steendijk P, Berger RM.

Int J Cardiol. 2013 Nov 5;169(3):183-9. doi: 10.1016/j.ijcard.2013.08.102. Epub 2013 Sep 7.

33.

Distinct loading conditions reveal various patterns of right ventricular adaptation.

Borgdorff MA, Bartelds B, Dickinson MG, Steendijk P, de Vroomen M, Berger RM.

Am J Physiol Heart Circ Physiol. 2013 Aug 1;305(3):H354-64. doi: 10.1152/ajpheart.00180.2013. Epub 2013 May 31.

34.

The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.

Dickinson MG, Bartelds B, Borgdorff MA, Berger RM.

Am J Physiol Lung Cell Mol Physiol. 2013 Jul 1;305(1):L1-14. doi: 10.1152/ajplung.00031.2013. Epub 2013 Apr 26. Review.

35.

Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.

Douwes JM, Roofthooft MT, Bartelds B, Talsma MD, Hillege HL, Berger RM.

Int J Cardiol. 2013 Sep 30;168(2):1370-7. doi: 10.1016/j.ijcard.2012.12.080. Epub 2013 Jan 20.

36.

Physiological interaction of heart and lung in thoracic irradiation.

Ghobadi G, van der Veen S, Bartelds B, de Boer RA, Dickinson MG, de Jong JR, Faber H, Niemantsverdriet M, Brandenburg S, Berger RM, Langendijk JA, Coppes RP, van Luijk P.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):e639-46. doi: 10.1016/j.ijrobp.2012.07.2362. Epub 2012 Sep 11.

37.

Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle.

Borgdorff MA, Bartelds B, Dickinson MG, Boersma B, Weij M, Zandvoort A, Silljé HH, Steendijk P, de Vroomen M, Berger RM.

Eur J Heart Fail. 2012 Sep;14(9):1067-74. doi: 10.1093/eurjhf/hfs094. Epub 2012 Jun 22.

38.

Lung irradiation induces pulmonary vascular remodelling resembling pulmonary arterial hypertension.

Ghobadi G, Bartelds B, van der Veen SJ, Dickinson MG, Brandenburg S, Berger RM, Langendijk JA, Coppes RP, van Luijk P.

Thorax. 2012 Apr;67(4):334-41. doi: 10.1136/thoraxjnl-2011-200346. Epub 2011 Dec 26.

PMID:
22201162
39.

Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load.

Bartelds B, Borgdorff MA, Smit-van Oosten A, Takens J, Boersma B, Nederhoff MG, Elzenga NJ, van Gilst WH, De Windt LJ, Berger RM.

Eur J Heart Fail. 2011 Dec;13(12):1275-82. doi: 10.1093/eurjhf/hfr134. Epub 2011 Oct 24.

40.

Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension.

Bartelds B, van Loon RLE, Mohaupt S, Wijnberg H, Dickinson MG, Boersma B, Takens J, van Albada M, Berger RMF.

Chest. 2012 Mar;141(3):651-660. doi: 10.1378/chest.11-0663. Epub 2011 Sep 22.

PMID:
21940767
41.

Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.

Dickinson MG, Bartelds B, Molema G, Borgdorff MA, Boersma B, Takens J, Weij M, Wichers P, Sietsma H, Berger RM.

Am J Pathol. 2011 Nov;179(5):2199-209. doi: 10.1016/j.ajpath.2011.07.030. Epub 2011 Sep 13.

42.

Neonatal myocardial infarction or myocarditis?

de Vetten L, Bergman KA, Elzenga NJ, van Melle JP, Timmer A, Bartelds B.

Pediatr Cardiol. 2011 Apr;32(4):492-7. doi: 10.1007/s00246-010-9865-8. Epub 2011 Jan 8.

43.

Gene expression profile in flow-associated pulmonary arterial hypertension with neointimal lesions.

van Albada ME, Bartelds B, Wijnberg H, Mohaupt S, Dickinson MG, Schoemaker RG, Kooi K, Gerbens F, Berger RM.

Am J Physiol Lung Cell Mol Physiol. 2010 Apr;298(4):L483-91. doi: 10.1152/ajplung.00106.2009. Epub 2009 Dec 18.

44.

Percutaneous atrial septal defect closure in patients with pulmonary hypertension.

Berger RM, Pricker K, Hoendermis ES, Bartelds B.

Heart. 2008 Dec;94(12):1653; author reply 1653-4. No abstract available.

PMID:
19011139
45.

Persistent pulmonary hypertension of the newborn with transposition of the great arteries.

Roofthooft MT, Bergman KA, Waterbolk TW, Ebels T, Bartelds B, Berger RM.

Ann Thorac Surg. 2007 Apr;83(4):1446-50.

PMID:
17383355
46.

Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase.

Exil VJ, Gardner CD, Rottman JN, Sims H, Bartelds B, Khuchua Z, Sindhal R, Ni G, Strauss AW.

Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1289-97. Epub 2005 Sep 30.

47.

Myocardial carnitine palmitoyltransferase I expression and long-chain fatty acid oxidation in fetal and newborn lambs.

Bartelds B, Takens J, Smid GB, Zammit VA, Prip-Buus C, Kuipers JR, van der Leij FR.

Am J Physiol Heart Circ Physiol. 2004 Jun;286(6):H2243-8. Epub 2004 Jan 29.

48.
49.

Alterations in adult rat heart after neonatal dexamethasone therapy.

de Vries WB, van der Leij FR, Bakker JM, Kamphuis PJ, van Oosterhout MF, Schipper ME, Smid GB, Bartelds B, van Bel F.

Pediatr Res. 2002 Dec;52(6):900-6.

PMID:
12438668
50.

Structural and functional genomics of the CPT1B gene for muscle-type carnitine palmitoyltransferase I in mammals.

van der Leij FR, Cox KB, Jackson VN, Huijkman NC, Bartelds B, Kuipers JR, Dijkhuizen T, Terpstra P, Wood PA, Zammit VA, Price NT.

J Biol Chem. 2002 Jul 26;277(30):26994-7005. Epub 2002 May 15.

Supplemental Content

Loading ...
Support Center